Tianjin Tasly in $24 Million Deal for EA Pharma Kidney Disease Drug

Life Science

Ascletis’ Hong Kong IPO to Raise $457 Million at $2 Billion Valuation

Life Science

Life Science & Technology Weekly 152 – China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing

Cannabis, Life Science

Aphria announces proposed acquisitions in Latin America, Jamaica worth around $200 million

Cannabis, Life Science

Fosun Pharma to Invest $17.6 Million in EOS Imaging of France

Life Science

Sinovant Formed with 11 China Drug Candidates and CITICPE Support

Life Science

Chinese Alzheimer’s Drug Ends Trials, Marketizes

Life Science

Taimi Bags Biggest Ever Investment in Medical Robot Sector

Life Science

China News Weekly 69 – Jack Ma to Co-Chair UN Panel on Digital Cooperation

Energy, Life Science, Mining, Technology

China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing

Life Science

HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery

Life Science

Lyvgen Biopharma Raises $30 Million for IO Drug Candidates

Life Science

Tasly In-licenses Two Cell Therapy Treatments in $90 Million Deal

Life Science

Ascentage Closes $150 Million C Round to Develop Apoptosis Drugs

Life Science

NAI500 Contributor Joseph Tang featured in Chinese Financial Media

Cannabis, Financial Service, Life Science